Corrections

Andrew Witty: the acceptable face of big pharma?

BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1579 (Published 08 March 2013) Cite this as: BMJ 2013;346:f1579

In this interview feature article by Rebecca Coombes we mixed up our currency symbols (BMJ 2013;346:f1458, doi:10.1136/bmj.f1458). GlaxoSmithKline’s fine was correctly quoted as $3bn at the start of the article but later rose wrongly to £3bn.

Notes

Cite this as: BMJ 2013;346:f1579

View Abstract